IGS1
vs
D
DAX Index
IGS1
Over the past 12 months, IGS1 has underperformed DAX Index, delivering a return of -21% compared to the DAX Index's +11% growth.
Stocks Performance
IGS1 vs DAX Index
Performance Gap
IGS1 vs DAX Index
Performance By Year
IGS1 vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
India Globalization Capital Inc
Glance View
India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The company is headquartered in Potomac, Maryland and currently employs 50 full-time employees. The company went IPO on 2006-04-13. IGC operates through two segments: Life Sciences and Infrastructure. Life Sciences segment involves the development of potential new drugs, hand sanitizers and several hemp-based Cannabidiol (CBD) products and brands, wholesale of hemp extracts, including hemp crude extract and hemp isolate, among others, white labeling of hemp-based products, and offering of tolling services like extraction and distillation to hemp farmers. Infrastructure segment involves execution of construction contracts, rental of heavy construction equipment and purchase and resale of physical commodities used in infrastructure. IGC'S Life Sciences brands include Hyalolex, Holi Hemp, Holief, Herbo, and Sunday Seltzer.
